These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6106364)

  • 1. Difference of effective antitrypanosomal dosages of benznidazole in mice and man. Chemotherapeutic and pharmacokinetic results.
    Richle RW; Raaflaub J
    Acta Trop; 1980 Sep; 37(3):257-61. PubMed ID: 6106364
    [No Abstract]   [Full Text] [Related]  

  • 2. Multiple-dose kinetics of the trypanosomicide benznidazole in man.
    Raaflaub J
    Arzneimittelforschung; 1980; 30(12):2192-4. PubMed ID: 6783051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Benznidazole and chronic Chagas disease].
    Manigot DA
    Medicina (B Aires); 1984; 44(1):105-6. PubMed ID: 6443011
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment with benznidazole or thioridazine in the chronic phase of experimental Chagas disease improves cardiopathy.
    Bustamante JM; Presti MS; Rivarola HW; Fernández AR; Enders JE; Fretes RE; Paglini-Oliva P
    Int J Antimicrob Agents; 2007 Jun; 29(6):733-7. PubMed ID: 17395432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benznidazole, a drug used in Chagas' disease, ameliorates LPS-induced inflammatory response in mice.
    Pascutti MF; Pitashny M; Nocito AL; Guermonprez P; Amigorena S; Wietzerbin J; Serra E; Bottasso O; Revelli S
    Life Sci; 2004 Dec; 76(6):685-97. PubMed ID: 15567193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinico-therapeutic trial with benzonidazole in Chagas' disease].
    Ferreira HD
    Rev Inst Med Trop Sao Paulo; 1976; 18(5):357-64. PubMed ID: 827007
    [No Abstract]   [Full Text] [Related]  

  • 7. Chronic Chagas' disease in the mouse. IV. Effect of trypanocidal drugs.
    Laguens RP; Cabeza Meckert P; Chambó JG; Gelpi R
    Medicina (B Aires); 1983; 43(2):126-30. PubMed ID: 6420640
    [No Abstract]   [Full Text] [Related]  

  • 8. [Benzonidazole: one of the rare treatment for Chagas disease].
    Coilliot C; Rouault M; Wolf A; Boulliat C; Beranger C; Gaillard K; Oliver M
    Med Trop (Mars); 2011 Feb; 71(1):25-7. PubMed ID: 21585085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of chronic Chagas' disease. Is the etiological treatment effective?].
    Rassi A; Rassi Júnior A
    Arq Bras Cardiol; 1998 Oct; 71(4):643-6. PubMed ID: 10347944
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of experimental chronic chagas disease with trifluralin.
    Zaidenberg A; Luong T; Lirussi D; Bleiz J; Del Buono MB; Quijano G; Drut R; Kozubsky L; Marron A; Buschiazzo H
    Basic Clin Pharmacol Toxicol; 2006 Apr; 98(4):351-6. PubMed ID: 16623857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should benznidazole be used in chronic Chagas' disease?
    Bestetti RB
    Lancet; 1997 Mar; 349(9052):653. PubMed ID: 9057760
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of immunosuppression and benzonidazole on Trypanosoma cruzi parasitism during experimental acute Chagas' disease.
    Okumura M; Mester M; Iriya K; Amato Neto V; Gama-Rodrigues J
    Transplant Proc; 1994 Jun; 26(3):1587-9. PubMed ID: 8030049
    [No Abstract]   [Full Text] [Related]  

  • 13. Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities.
    Viotti R; Vigliano C; Lococo B; Alvarez MG; Petti M; Bertocchi G; Armenti A
    Expert Rev Anti Infect Ther; 2009 Mar; 7(2):157-63. PubMed ID: 19254164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trypanosoma cruzi: alteration in the lymphoid compartments following interruption of infection by early acute benznidazole therapy in mice.
    Olivieri BP; de Souza AP; Cotta-de-Almeida V; de Castro SL; Araújo-Jorge T
    Exp Parasitol; 2006 Nov; 114(3):228-34. PubMed ID: 16620811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effects of benznidazole during an infectious-based situation of systemic inflammatory response: cecal ligation and puncture.
    Manarin R; Bottasso E; Bottasso O; Serra E; Revelli S
    Am J Trop Med Hyg; 2008 Nov; 79(5):793-6. PubMed ID: 18981524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of the polymerase chain reaction for monitoring cure of mice infected with different Trypanosoma cruzi clonal genotypes following treatment with benznidazole.
    Miyamoto CT; Gomes ML; Marangon AV; de Araújo SM; Bahia MT; Martins-Filho OA; de Lana M; de Ornelas Toledo MJ
    Exp Parasitol; 2008 Sep; 120(1):45-9. PubMed ID: 18533149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A high-performance liquid chromatographic method for benznidazole quantitation in plasma of patients with Chagas disease.
    Guerrero L; Pinazo MJ; Posada E; Gascón J; Ribas J; Soy D
    Clin Chem Lab Med; 2011 Jan; 49(1):77-82. PubMed ID: 21083440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitrypanosomal therapy for chronic Chagas' disease.
    Bestetti RB; Cardinalli-Neto A
    N Engl J Med; 2011 Sep; 365(13):1258-9; author reply 1259. PubMed ID: 21991909
    [No Abstract]   [Full Text] [Related]  

  • 19. Antitrypanosomal therapy for chronic Chagas' disease.
    Garcia-Bournissen F; Altcheh J
    N Engl J Med; 2011 Sep; 365(13):1258; author reply 1259. PubMed ID: 21991908
    [No Abstract]   [Full Text] [Related]  

  • 20. [Allopurinol in the treatment of chronic Chagas' disease].
    Meirovich CI; Montrull HL; Gallerano RH; Sosa RR
    Arq Bras Cardiol; 1985 Sep; 45(3):217-23. PubMed ID: 3939099
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.